|
Advantages and limitations of the inclusion of ascorbic acid on nitrosamine mitigation in pharmaceutical drug products-Pub
|
|
5
|
428
|
February 17, 2026
|
|
Detecting Nitrosamines & Mutagenic Impurities
|
|
0
|
204
|
January 12, 2026
|
|
Monitoring the Concentration of Nitrogen Oxides in the Fluidized Bed Drying/Granulation Process and Evaluation of Reduction Methods
|
|
2
|
476
|
September 28, 2025
|
|
Nitrosamines risk in cleaning validation approach
|
|
11
|
369
|
September 4, 2025
|
|
MEGLUMINE (Methylglucamine)
|
|
27
|
3463
|
July 10, 2025
|
|
Mitigation of N-Nitrosamine Formation in Ranitidine Hydrochloride by Spray Drying Co-Precipitation with Mannitol, Dextrin, and Antioxidant-Pub
|
|
0
|
137
|
June 21, 2025
|
|
N-nitrosodicyclohexylamine (NDCHA), what do you know about it?
|
|
18
|
614
|
March 21, 2025
|
|
Exploration for Chemical Filter Cartridges that Can Reduce Nitrogen Oxides, a Common Factor in the Formation of Nitrosamines
|
|
0
|
274
|
December 15, 2024
|
|
Primeros pasos para evaluar nitrosaminas en medicamentos
|
|
5
|
282
|
September 23, 2024
|
|
Potential Topic for an event concerning obtaining the right level of Nitrosamine Risk Assessment information from your CMOs
|
|
22
|
1732
|
September 5, 2024
|
|
Control limit of Nitrosamines and N-nitroso compounds
|
|
2
|
503
|
July 8, 2024
|
|
Risk analysis of nitrosamine impurities in liquid products (essences and flavors)
|
|
3
|
768
|
June 28, 2024
|
|
Discussion on Cleaning Validation Requirements for Nitrosamines
|
|
3
|
1129
|
June 24, 2024
|
|
Update: EFPIA workflows for Quality Risk management Jun 2024 v03
|
|
2
|
1271
|
June 4, 2024
|
|
AI Limit for Nitroso Nebivolol
|
|
11
|
2906
|
April 3, 2024
|
|
N- nitroso Nitazoxanide
|
|
1
|
577
|
February 8, 2024
|
|
Nitrosamine Impurities in Topical Drug Product
|
|
3
|
660
|
February 3, 2024
|
|
10º encontro Farmacopeia Brasileira
|
|
0
|
532
|
November 30, 2023
|
|
Nitrosamines risk assessments for Topical herbal extracts
|
|
1
|
557
|
September 20, 2023
|
|
Apixaban Drug Substance-Related Impurities (NDSRIs)
|
|
3
|
1708
|
September 15, 2023
|
|
Total impurities limit if more than one nitrosamine impurities are observed in product
|
|
4
|
720
|
August 14, 2023
|
|
The Nitrosamine “Saga”
|
|
3
|
1653
|
July 29, 2023
|
|
FDA Workshop: Mitigation Strategies for Nitrosamine Drug Substance Related Impurities
|
|
11
|
4002
|
July 27, 2023
|
|
NDSRIs: Atualizações e Desafios
|
|
0
|
497
|
July 24, 2023
|
|
N-nitroso Des-methyl Dapoxetine
|
|
12
|
1326
|
May 31, 2023
|
|
Setting limit for Nitrite and Nitrate in water used for Active Ingredients synthesis
|
|
2
|
1604
|
May 23, 2023
|
|
Carry over limits for Niitrsoamines
|
|
2
|
792
|
February 12, 2023
|
|
Nitrosamine risks that may arise from the filters
|
|
2
|
863
|
January 4, 2023
|
|
Cleaning Validations Criteria
|
|
1
|
1905
|
December 5, 2022
|
|
2 days seminar on nitrosamine and extractable & leachable
|
|
0
|
581
|
November 21, 2022
|